Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?
Bonastre, Julia
Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals? [electronic resource] - Health policy (Amsterdam, Netherlands) Jun 2014 - 162-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-6054
10.1016/j.healthpol.2013.11.006 doi
Antineoplastic Agents--economics
Breast Neoplasms--drug therapy
Diagnosis-Related Groups--economics
Diffusion of Innovation
Drug Costs--statistics & numerical data
Female
France--epidemiology
Health Services Accessibility--economics
Hospitals, Private--economics
Hospitals, Public--economics
Humans
Male
Models, Statistical
Neoplasms--drug therapy
Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals? [electronic resource] - Health policy (Amsterdam, Netherlands) Jun 2014 - 162-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-6054
10.1016/j.healthpol.2013.11.006 doi
Antineoplastic Agents--economics
Breast Neoplasms--drug therapy
Diagnosis-Related Groups--economics
Diffusion of Innovation
Drug Costs--statistics & numerical data
Female
France--epidemiology
Health Services Accessibility--economics
Hospitals, Private--economics
Hospitals, Public--economics
Humans
Male
Models, Statistical
Neoplasms--drug therapy